PP_1170x120_10-25-21

HempFusion unveils O-T-C topical products for targeted relief

Print Friendly, PDF & Email

DENVER — HempFusion has launched  its Food and Drug Administration  listed Over-the-Counter Topical Products featuring scientifically documented active ingredients targeting specific consumer needs including menthol, salicylic acid, and colloidal oatmeal, providing relief for pain, acne, eczema and more.

HempFusion® Launches Innovative Over-the-Counter (“OTC”) Topical Products Allowing For Targeted Relief (CNW Group/Hemp Fusion)

HempFusion is excited to offer consumers access to FDA listed topical solutions, backed by scientifically documented active ingredients formulated in a proprietary cosmetic ingredient base. This includes aloe vera, jojoba oil, shea butter, essential oils and HempFusion’s premium panoramic Full-Spectrum hemp extract featuring CBD and other naturally occurring cannabinoids as well as terpenes for their skin conditioning and moisturizing benefits, and so much more.

“With the launch of our innovative O-T-C Topicals line, HempFusion provides consumers with high quality O-T-C products that are backed by science”, stated Jason Mitchell, co-CEO of HempFusion. “By producing and marketing these products in accordance with the FDA’s O-T-C regulations, we are able to utilize active ingredients that target specific conditions for a variety of consumer needs, which we believe has the ability to substantially increase our customer base”, continued Mitchell.

The company’s O-T-C Topical line, now available on www.hempfusion.com, provides consumers with a wide selection of creams and balms, including an ointment and gel, specifically targeting the following:

Pain Relief:

  • Pain Relief Cream
  • Pain Relief Balm
  • Sports Pain Relief Cream
  • Sports Pain Relief Balm
  • Pain Relief Gel including moisturizing Arnica Extract

HempFusion Formulas for Skin Conditions:

  • Eczema Relief Cream
  • Acne Relief Cream
  • Wound Ointment Antibiotic First Aid

“We believe these new product offerings will increase our customer base by providing  concerned retailers with the ability to stock our O-T-C Topicals with confidence that these products follow the FDA’s OTC guidelines,” added Ian deQueiroz co-CEO of HempFusion. “We anticipate this specialized line has the potential to be a significant revenue driver and division of the company,” continued deQueiroz.


ECRM-08-202222

Adheris Health

Comments are closed.

Adheris Health